Yahoo Web Search

Search results

1. • 

     New Trials in Prostate Cancer: Could Your Patient Benefit?

     Medscape· 18 hours ago

     Perhaps one of your patients could benefit from a clinical trial that has recently opened in ...

2. • 

     Men on hair-loss drug warned of sexual and psychiatric side effects

     The Telegraph via Yahoo News· 4 hours ago

     It has also ordered suppliers of finasteride to now include a patient alert card in packs of the ...

3. • 

     Q&A: Harnessing the power of the immune system to combat cancer

     Digital Journal· 2 hours ago

     Immunotherapy promises to deliver significant results in the battle against different forms of ...

4. • 

     These Are the Drugs America Is Running Short On

     247wallst.com· 6 hours ago

     Drug shortages in America are the result of supply line challenges, profit-based operations, and company closures.

5. • Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...

     Morningstar· 6 days ago

     XTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer ...

6. • 

     Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

     Investor's Business Daily· 4 days ago

     The Swiss drugmaker's success has caught Big Pharma's attention, sparking an M&A spree that sent...

7. • 

     Is the FDA Pausing More Cancer Trials? It's Hard to Tell

     Medscape· 6 days ago

     Is the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration...

8. • 

     King Charles: What kind of cancer treatment is available to him - and what impact could it have

     The Independent via Yahoo News· 3 days ago

     The drugs seek to disrupt the way cancer cells grow and drive but can also damage some of the health...

9. • 

     Rakovina Therapeutics: AI a “paradigm shift” for cancer drug development

     Proactive Investors· 5 days ago

     Teaming up with Dr. Artem Cherkasov from the University of British Columbia, Rakovina gained...

10. • 

      AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect

      Zacks via Yahoo Finance· 6 days ago

      A phase III registrational study is expected to begin in 2025. For the acquisition, AstraZeneca...